ABA is a ubiquitous inhibitory neurotransmitter, reducing neuronal excitability by receptor-mediated hyperpolarization of membrane potential and shunting of excitatory currents. GABA A receptors are hetero-pentameric Cl − -conducting channels 1 . GABA B receptors are hetero-dimeric metabotropic receptors that are coupled to multiple ionic currents by G i/o -proteins 2 and are more sensitive to GABA than most synaptic GABA A receptors 3 . Despite the clinical efficacy of drugs that alter GABAergic neurotransmission, the details of GABA release from neurons remain largely unknown. GABA signaling has traditionally been inferred from a combination of electrophysiology and pharmacology 4 . Direct detection of GABA has required microdialysis followed by derivatization and quantification by HPLC and electrochemistry 5 , but this technique has an inherently poor spatiotemporal resolution (on the order of minutes and hundreds of microns).
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Although genetically encoded fluorescent sensors for calcium [6] [7] [8] have been optimized for imaging neural activity and sensors for the excitatory neurotransmitter glutamate 9 have been developed, methods for directly imaging GABAergic signaling are lacking. A semisynthetic sensor with organic fluorophores attached to the GABA B receptor was reported 10 , but its low affinity for GABA (400 µM) and dependence on two small molecules limit utility. Inhibitory neurotransmission can be inferred from the intracellular chloride concentration, [ 12, 13 .
We have generalized the development of genetically encoded sensors from bacterial periplasmic binding proteins (PBPs) by insertion of circularly permuted fluorescent proteins 14 , including a glutamate sensor for in vivo imaging 9 . Here we report the development of an iGABASnFR and observe GABA uptake into mitochondria and GABA release in cultured neurons and acute mouse brain slice. In vivo, we observed bulk GABA transients in mouse visual cortex, and GABA release synchronized with interictal spikes and seizures in a chemoconvulsant mouse model of epilepsy. In zebrafish, we used iGABASnFR to correlate GABAergic signals across the cerebellum to motor output.
Results
Sensor engineering. There are many potential scaffolds for developing a GABA sensor. GABA A and GABA B receptors are inappropriate since the GABA binding sites of the former are at protein-protein interfaces 1 (rather than intramolecular) and the latter is difficult to express heterologously 15 . Furthermore, over-expression of these receptors could alter cellular physiology. In theory, one could redesign the binding site of an existing sensor (for example iGluSnFR) to make it specific for GABA. However, our attempts to do so failed (data not shown).
GABA is a prominent signaling molecule in plants. The plant pathogen Agrobacterium tumefaciens expresses two periplasmic GABA binding proteins. We developed a sensor from Atu2422 (ref. 16 ), but it has low (high-μM) affinity for GABA and ordersof-magnitude higher (low-μM) affinity for alanine and proline ( Supplementary Fig. 1 ). Atu4243 has more stringent specificity and higher affinity for GABA (9 µM) 17 . Unfortunately, Atu4243 with either cpGFP (circularly permuted green fluorescent protein) or cp-superfolder GFP (cpSFGFP) inserted at various locations Articles Nature Methods did not translocate to the membrane surface in cultured cells ( Supplementary Fig. 2 ) and was abandoned.
Before the structures of Atu2422 and Atu4243 were published, a strain of Pseudomonas fluorescens (ATCC no. BAA1781) was reported to take up GABA 18 . We sequenced the genome of this strain (CNG89; a gift from Dr. Catherine Guthrie). We identified 'Pf622' as a homolog of Atu4243 ( Supplementary Fig. 3 ) and expressed it heterologously in Escherichia coli. The affinity of the protein was not in the low-nM range as expected 18 , but rather ~110 µM as determined by isothermal titration calorimetry ( Supplementary Fig. 4) . A fluorescent allosteric signal transducer 19 , introduced by attaching an environmentally sensitive fluorophore, JF585 (ref. 20 ), via maleimide-thiol chemistry to a cysteine mutation at a residue in the hinge of the protein (V278C), resulted in a hybrid sensor with 240 µM affinity for GABA ( Supplementary Fig. 5 ). Stopped-flow analysis revealed atypical kinetics. Instead of a single exponential rise in fluorescence upon the mixing of protein and GABA, the data is best fit by a double exponential ( Supplementary Fig. 6a,b) , suggesting that multiple steps link GABA binding to fluorescence change (see below). Regardless, the rise time for Pf622.V278C-JF585 binding GABA is longer than it is for iGluSnFR binding glutamate ( Supplementary Fig. 6c ).
Pf622 with cpGFP or cpSFGFP (whose substitution for cpGFP in iGluSnFR 9 improved expression and photostability) inserted at any of several sites translocated to the membrane when cloned into pDisplay and expressed in mammalian cells ( Supplementary  Fig. 7 ). We inserted cpSFGFP after residue 276 of Pf622 ( Fig. 1a ; Supplementary Fig. 8 ), optimized binding protein-to-FP linkers, yielding a first-generation sensor (L1-LA/L2-AN), and solved its crystal structure in the unliganded, open state (Fig. 1b, Supplementary  Fig. 9 , PDB accession 6DGV). The homology of Pf622 to Atu4243, for which both the unliganded, open and bound, closed structures are available 17 , allowed us to test mutations to the hinge region of Pf622 expected to allosterically modulate affinity 21 . Hinge mutation F101L increased affinity 10-fold ( Supplementary Fig. 10 ). Mutation of a residue in Pf622 (N260A) that potentially interacted with cpSF-GFP, and was also a potential glycosylation site, increased brightness in HEK cells ( Supplementary Fig. 11 ). Re-optimization of the linkers (L1-LAQVR, L2-AN), plus the SFGFP mutation F145W, resulted in a variant, called iGABASnFR, worthy of further characterization. In summary, iGABASnFR is Pf622 with cpSFGFP inserted after residue 276, with optimized linkers (L1-LAQVR, L2-AN), a hinge mutation (F101L), an interface and expression mutation (N260A) and an additional GFP mutation (F145W).
In vitro characterization. Purified iGABASnFR shows a maximum ∆F/F of ~2.5, where ΔF/F = (F-F 0 )/F 0 and F 0 is basal fluorescence, and a dissociation constant (K d ) for GABA of ~9 µM ( Supplementary  Fig. 12a ). It shows no affinity for other amino acids except very low affinity for glycine (500 µM), alanine (830 µM) and histidine (2.4 mM) ( Supplementary Fig. 12b ). It has no affinity for similar four-carbon metabolites fumarate, malate, oxaloacetate, nor succinate (data not shown). As we characterized iGABASnFR in cellular systems, we made additional efforts to increase its affinity and ∆F/F. Mutation of a GABA-binding pocket residue to its Atu4243 homolog, F102Y, had minimal effect on GABA affinity and decreased ∆F/F. Meanwhile, the mutation Y137L increased ∆F/F, at the cost of poor expression. The double mutant F102Y.Y137L expressed well, exhibited higher ∆F/F (3.5 versus 2.5 for iGABASnFR) but lower affinity (70 μM versus 9 μM for iGABASnFR; Supplementary  Fig. 12a ). Addition of F102G to iGABASnFR (without changes to Y137) showed higher ∆F/F (4.5) and affinity of 50 μM. We created a non-binding variant by mutating a binding pocket residue (R205A). iGABASnFR and the + F102G and + F102Y.Y137L variants were further characterized.
We profiled the iGABASnFR variants for binding to GABAergic drugs ( Supplementary Fig. 12c-f) . Baclofen (β-(4-chlorophenyl)-GABA) affected all three iGABASnFR variants tested (as well as Articles Nature Methods the negative control cpSFGFP, Supplementary Fig. 12c ), whereas vigabatrin (γ-vinyl-GABA, Sabril) bound to only iGABASnFR. F102G. All three variants are also high-affinity sensors for muscimol ( Supplementary Fig. 12c -f, pink traces). Importantly, all other drugs showed much weaker binding to the sensors than GABA, allowing them to be used in conjunction with iGABASnFR imaging. The absorbance, excitation and emission profiles of iGABASnFR show that fluorescence changes result from increased excitation at 485 nm when GABA is bound, and is reflected in the two-photon cross sections of all three iGABASnFR variants ( Supplementary Fig. 13 ). The iGABASnFR variants are more sensitive to pH in the unbound state than the GABA-bound state ( Supplementary Fig. 14) . Unlike other PBP-based sensors 9, 21 , the rate of fluorescence change for iGABASnFR as determined by stopped-flow kinetics was largely independent of the concentration of ligand used ( Supplementary Fig. 15 ).
GABA processing in mitochondria. After being transported into mitochondria (by an as yet unidentified transporter), GABA is degraded by GABA transaminase (GABA-T). Inhibition of GABA-T elevates synaptic levels of GABA 22 and, of clinical significance, the GABA-T inhibitor vigabatrin is a prescribed antiepileptic 23 . We transfected cultured prostate cancer cells (LNCaP) with iGABASnFR. F102Y.Y137L (which does not bind vigabatrin; Supplementary Fig.  12f ), fused to an N-terminal mitochondrial matrix targeting motif from Cox8a (mito-iGABASnFR.F102Y.Y137L). Basal fluorescence was low ( Supplementary Fig. 16 ), consistent with the observation that these cells contain little GABA 24 . Exogenous GABA increased fluorescence within the mitochondria as expected ( Supplementary  Fig. 17a,b) , reaching equilibrium after 48 h, presumably reflecting both increasing mito-iGABASnFR expression and continued GABA uptake. The GABA-binding dependence of mitochondria-localized iGABASnFR is hyperbolic ( Supplementary Fig. 17c ). Vigabatrin treatment tends to increase iGABASnFR fluorescence in mitochondria ( Supplementary Fig. 17d ). Transfection of mito-iGABASnFR.
F102Y.Y137L expressing LNCaP cells with a plasmid encoding glutamic acid decarboxylase 1 (GAD67) resulted in increased endogenous GABA synthesis ( Supplementary Fig. 17e ).
Neuronal culture characterization. iGABASnFR variants cloned into a modified version of pDisplay lacking the HA tag expressed in HEK cells and showed good membrane localization ( Supplementary Fig. 11 ). Similarly, iGABASnFR showed good membrane localization and brightness at 14 d in vitro (DIV) in primary culture of hippocampal neurons from P0 newborn rats after infection with AAV2/1. hSynapsin1.iGABASnFR, but the +F102G and +F102Y.Y137L variants were noticeably dimmer and showed intracellular accumulation ( Supplementary Fig. 18 ). Perfusion of neuronal cultures with GABA revealed affinities for GABA similar to, but slightly weaker than, purified protein (iGABASnFR, 30 µM; +F102G, 42 µM; +F102Y.Y137L, 106 µM; Supplementary Fig. 19 ).
Electrical field stimulation (50 Hz) of the cultured neurons produced fluorescence changes from single stimulus-evoked action potentials and increased until plateauing after 40 stimuli (Fig. 1c) . The fluorescence change of iGABASnFR was restricted to the membrane (Fig. 1d) , as with SF-iGluSnFR, but with an order of magnitude lower maximal response ( Supplementary Fig. 20a ). The iGABASnFR response within a field of view was also less uniform than SF-iGluSnFR ( Supplementary Fig. 20b -e), consistent with GABAergic neurons representing a smaller fraction (~10%) of the neuronal population in the hippocampal culture 25 .
Hippocampal acute slice. To confirm that iGABASnFR remains functional in brain tissue, we examined hippocampal acute slices prepared from mice injected with AAV2/1.hSynapsin1.iGABASnFR. Although it was challenging to reliably record GABA release at individual synapses (data not shown), which was possible for glutamate recording with iGluSnFR 12, 13 , iGABASnFR displayed excellent signal-to-noise ratio following paired pulse extracellular field Articles Nature Methods stimulation in stratum radiatum. iGABASnFR responses to extracellular GABA transients were recorded from apical dendritic segments traced from the CA1 pyramidal cell body (Fig. 2a) . Raising extracellular calcium increased fluorescence response amplitude (Fig. 2b,c) , consistent with increased presynaptic release probability 26 .
Somatosensory cortex acute slice. We also probed the effect of iGABASnFR expression on post-synaptic signaling. Since the sensor is derived from a bacterial binding protein, it is unlikely to interact with GABA A or GABA B receptors. In acute brain slices of mouse somatosensory cortex, whole-cell patch-clamp recordings of uninfected and AAV.hSynapsin1.iGABASnFR infected cells showed resting potentials near the expected −70 mV ( Supplementary Fig. 21a ). Patched cells were observed for 100 s with inhibitory and excitatory post-synaptic currents (IPSCs and EPSCs) electrically stimulated every 10 s. Evoked excitatory current from cells expressing iGABASnFR were statistically indistinguishable from uninfected cells ( Supplementary Fig. 21b ,c; P = 0.63 for evoked EPSC peak currents; P = 0.35 for evoked IPSC peak currents; Mann-Whitney U-test). Spontaneous post-synaptic currents (PSCs) were observed in the intervening periods ( Supplementary Fig. 21d ). The amplitudes of these spontaneous PSCs were similar (spontaneous mean amplitude for EPSCs, P = 0.97; IPSCs, P = 0.82; Supplementary  Fig. 21e ), as were the amplitude variances (spontaneous amplitude s.d. for EPSCs, P = 0.92; IPSCs, P = 0.92; Mann-Whitney U-test; Supplementary Fig. 21f ). Evoked responses measure purely postsynaptic activity, while spontaneous activity is also influenced by differences in network connectivity and inputs, which vary from cell to cell. So, although we observed a higher (but statistically insignificant) frequency of spontaneous IPSCs in iGABASnFR-expressing cells (0.19 Hz versus 0.12 Hz, P = 0.066; Mann-Whitney U-test; Supplementary Fig. 21g ), the absence of other differences between iGABASnFR infected and uninfected cells leads us to believe that the observed higher frequency of IPSCs in iGABASnFR cells is coincidental.
Volume detection of GABA in mouse visual cortex. In the visual cortex, GABAergic inhibition 27 and disinhibition 28 contribute to context-dependent processing and can enhance the distinctness of sensory responses. Hypnotic effects of anesthetics have been Articles Nature Methods associated with GABAergic transmission 29 . Volatile anesthetics decrease both glutamatergic and GABAergic synaptic transmission in the cortex, with stronger effects on glutamate currents, leading to net inhibition of activity 30 . Anesthetics can, therefore, be used to determine whether iGABASnFR can detect decreases in cortical GABA release relative to basal rates, which may reflect tonic 31 or ongoing phasic release.
To directly monitor cortical GABA in a time-and depth-resolved manner, we injected AAV2/1.hSynapsin1.iGABASnFR into mouse primary visual cortex (V1) and measured fluorescence (with 1030 nm excitation) in a 150 × 150 × 450 µm 3 deep volume over the course of 40 min. After 8 min, we administered isoflurane anesthesia, which is expected to suppress inhibition. Fluorescence decreased 20% during anesthesia treatment and slowly returned to baseline during recovery ( Supplementary Fig. 22a,b) . In parallel experiments with the non-GABA-binding negative control (R205A), fluorescence decayed slowly over the observation period, with no recovery after removal of anesthesia (Supplementary Fig. 22c ).
In vivo mouse model of epilepsy. Having established that iGABASnFR robustly detects synchronous release events, we tested it in small-scale, high-resolution, two-photon neuropil imaging experiments. Focal neocortical epilepsy is typically accompanied by abnormal background electrocorticogram (ECoG) activity, including frequent interictal spikes (occurring between seizures), which are dominated by GABAergic activity 32 . How seizures intermittently arise from this background is poorly understood. Numerous mechanisms have been proposed, although the strongest evidence supports a failure of feed-forward inhibition 33, 34 . This could, in principle, arise because interneurons enter a state of depolarization block in the face of over-excitation and fail to release GABA, or because shifts in the chloride reversal potential in principal cells resulting from intense GABA release render GABA A receptor-mediated inhibition ineffective 35 . These hypotheses are not mutually exclusive, but important insights could be provided by imaging extracellular GABA during interictal spiking and seizures. If extracellular GABA transients collapse rapidly at the onset of seizures, this would argue for depolarization block of interneurons, or another mechanism by which interneurons fail to be recruited or release GABA.
We injected AAV2/1.hSynapsin1.iGABASnFR (or variants) into layer 2/3 of mouse V1 (Fig. 3a-d) . Intracortical pilocarpine injection elicited focal epileptiform activity lasting up to 60 min 36 . This consisted of periods of interictal spiking alternating with polyspikes and ECoG seizures lasting 1-2 min. iGABASnFR fluorescence reliably showed transients time-locked to interictal spikes (Fig. 3e-g ). Comparing across the different sensors, iGABASnFR and iGABASnFR.F102G gave the largest ΔF/F, iGABASnFR.F102Y.Y137L gave lower ΔF/F and iGABASnFR. R205A was unresponsive (Fig. 3h ). During periods with stereotyped polyspikes, fluorescence peaks separated by <1 s could be resolved with iGABASnFR.F102G (Fig. 4a,b) . Discrete peaks coinciding with low-frequency ECoG components could still be seen during focal seizures lasting up to 1 min (Fig. 4c) . Fluorescence gradually decreased during seizures, slowly recovering during intervals of electrographic silence between seizures (Fig. 4c,d ). As this slow decrease was not seen during interictal events and polyspikes ( Fig. 3e and Fig. 4a,b) , it cannot be attributed to photobleaching. It is, however, consistent with iGABASnFR acidification (Supplementary Fig. 14) . Extracellular acidification during seizures has been documented abundantly and has been proposed to contribute to seizure termination 37 . The decrease in fluorescence (starting 1 s after the onset of the seizure, Fig. 4d ) yielded a monoexponential decay time constant of approximately 12.1 s, similar to the time constant for pH changes in astrocytes during seizures (~14.7 s, ref. 38 ). Fluorescence increased during periods of electrographic silence between seizures, consistent with pH returnto-baseline. (A monoexponential curve fit from the end of one seizure to the start of the next (average time interval around 8.2 s) yielded a time constant around 16 s). Although this account of changes in fluorescence is consistent with a surge in GABA and changes in extracellular pH, further experiments using a GABA-insensitive pH indicator, such as pHluorin, or an improved pH-insensitive GABA sensor, would help to distinguish the two phenomena. GABA in zebrafish cerebellum. As a final demonstration of iGABASnFR in vivo, we observed GABA transients in Danio rerio (zebrafish) cerebellum using light-sheet imaging in a fictive model of swimming 39 ( Fig. 5a ). In zebrafish, fictive swimming triggers robust activation of GABAergic cerebellar Purkinje cells 40 . We generated a transgenic zebrafish expressing iGABASnFR.F102Y.Y137L (available before iGABASnFR.F102G was identified) under the elavl3/HuC pan-neuronal promoter (Fig. 5b) . During swim bouts, we observed reliable fluorescence changes in cerebellar neuropil regions containing GABAergic Purkinje cell axons 41 ( Fig. 5c,d , Supplementary Video 1). Changes in fluorescence peaked roughly 200 ms after the onset of swimming (Fig. 5e) , with this region producing >8% fluorescence increases. This result indicates that iGABASnFR can reliably detect local GABA transmission that may play a critical role in motor control.
Discussion
To understand neural circuit function, numerous specific inputs onto neurons must be disentangled from their integrated output. Current sensor technologies, namely SF-iGluSnFR 9 , GCaMP6 (ref. 7 ) and jGCaMP7 (ref. 8 ) and jRGECO 6 , are sensitive enough to allow reliable detection of excitatory synaptic transmission, excitatory post-synaptic currents and action potentials. Indicators for inhibitory synaptic transmission and inhibitory post-synaptic currents have lagged far behind. iGABASnFR offers the best performance of existing GABA indicators and is the only one to be genetically encoded completely, facilitating in vivo use. Calcium and glutamate sensors have been iteratively optimized, both to improve overall performance and to match the precise requirements of specific settings. We expect further development of iGABASnFR, with altered affinity and kinetics and improved signal-to-noise ratio. Different colors of iGABASnFR could also be developed, allowing simultaneous imaging in orthogonal chromatic channels, as has been done with iGluSnFR 9, 42 . More sensitive indicators will be required to facilitate single-spine GABAergic imaging and the separation of phasic from tonic signaling. It is important to note the value of spatially resolvable readout of synaptic GABA release given the highly organized, cell typespecific nature of GABAergic innervation onto pyramidal cells 43 . Imaging in different cellular compartments enables the highthroughput study of GABA release from different populations of interneurons. Combined with patch-clamp electrophysiology and Ca 2+ imaging with red-shifted indicators, iGABASnFR could allow direct study of the local signaling requirements underlying important physiological phenomena such as depolarization-induced inhibition suppression 44 . In our data, GABA release does not collapse completely during seizures. However, our experiments do not rule out the partial failure of GABA release when seizures start, due either to exhaustion of releasable GABA vesicles or to depolarization block in a subset of interneurons. Indeed, we imaged very superficial cortex, restricting the observation of GABA release to pyramidal neuron dendrites and layer 1 interneurons. Ultimately, to understand the role of GABA during seizures, more extensive experiments involving different interneuron types, simultaneous glutamate imaging and controlling for pH is needed.
We hope that the demonstrated use of iGABASnFR in models of epilepsy and in the cerebellum of fictively behaving zebrafish will help elucidate the role of GABA in various circuits, during development and in disease states. Aberrations in GABAergic signaling occur in Alzheimer's disease , schizophrenia 48 , autism 49 and Rett syndrome 49 . The imaging of iGABASnFR in appropriate animal models will facilitate a greater understanding of these mechanisms. iGABASnFR could also allow easy screening of candidate transporters such as the vertebrate mitochondrial GABA transporter. Applications outside neuroscience are also possible, such as separating the critical roles of GABA in plant metabolism and signaling.
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Methods
Sequencing of the Pseudomonas fluorescens strain CNG89 genome. Genomic DNA was prepared using a QIAamp DNA mini kit (Qiagen). Genomic DNA was sequenced using a combination of Ion Torrent PGM and Illumina HiSeq technologies and assembled using Spades software with default parameters. Draft genome assembly (131 scaffolds; 141,337 base pairs median scaffold length, N 50 ) was sufficient to facilitate tblastn of the Agrobacterium tumefaciens Atu4243 sequence to prioritize putative GABA-binding proteins. The complete genome assembly is ongoing and will be published elsewhere.
Cloning and mutagenesis. The gene for Pf622, lacking the periplasmic leader sequence, was amplified by PCR and cloned into pRSET-A (Invitrogen) by BamHI and EcoRI digest. Silent mutations were made to remove an internal PstI restriction site. The Pf622 gene was then re-cloned into a derivative of pRSET that has the N-terminal affinity and epitope tags replaced by an Arg-Ser encoding BglII site and a C-terminal Leu-Gln-His 6 sequence (with PstI encoding Leu-Gln). This pRSET derivative was created to facilitate downstream cloning of iGABASnFR variants into AAV vectors. Genes for Pf622-cpSFGFP insertions were made by overlapping PCR.
Mutant screening.
Mutations to iGABASnFR variants were made by the uracil template-based method 50 . Mutations were initially targeted to the junction of Pf622 and cpSFGFP and expanded to include other residues as the sensor was improved. Mutated plasmids were transformed into T7 express cells (New England BioLabs), plated on Luria broth agar plates with 100 µg ml −1 ampicillin and grown overnight at 37 °C. Colonies were transferred to 2 ml 96-well plates containing 0.9 ml auto-induction media 51 with 100 µg ml −1 ampicillin and grown overnight with vigorous shaking (400 r.p.m.) at 30 °C. Bacterial pellets were collected by centrifugation (3000g), resuspended in 0.5 ml PBS by vortexing to wash away endogenous GABA and then pelleted again. The wash procedure was repeated five times, and pellets were frozen overnight at −20 °C. Frozen bacterial pellets were then lysed by the addition of 1 ml PBS and vortexing. Cellular debris was pelleted by centrifugation and clarified lysate removed for fluorescence assays by pipetting.
The green fluorescence (excitation 485 nm, emission 515 nm, 5 nm bandpass) of 100 µl clarified lysate was measured in a Tecan Infinite M1000 Pro plate-reading fluorimeter. GABA was added to a final concentration of 1 mM and fluorescence was measured again. Variants with increased ∆F/F over the starting construct were immediately re-assayed to estimate binding affinity, and the best were streaked out on agar plates, re-isolated, re-assayed and sequenced.
Protein expression, purification and in vitro characterization. Final variants of iGABASnFR were expressed as above, but on a larger scale (0.5 l) and pelleted by centrifugation, resuspended in PBS and frozen overnight. Cells were lysed by thawing and sonication. Lysate was clarified by centrifugation at 35,000g and purification by immobilized metal affinity chromatography on a 5 ml fast flow chelating sepharose column (GE Life Sciences) with an elution gradient from 0 to 200 mM imidazole over 120 ml. Fluorescent fractions were pooled, concentrated by spin concentrator and dialyzed five times in PBS. Equilibrium binding affinities were determined by titration with serial dilutions of GABA (or other compounds) into 0.2 µM protein solution in PBS. Kinetics of binding were determined by mixing equal volumes of 0.2 µM protein with varying concentrations of GABA in an Applied Photophysics SX20 stopped-flow fluorimeter with 490 nm LED excitation and 510 nm long pass filter. Circular dichroism was measured with 20 µM protein in 0.1× PBS in an Applied Photophysics Chirascan with 1 s data collection periods and 300 s settling time at each temperature point. Twophoton cross sections were collected for 1 µM solutions of protein in PBS with or without 10 mM GABA, excited by pulses from a mode-locked Ti:Sapphire laser (Chameleon Ultra, Coherent, 80 MHz, 140-fs pulse width, 1 mW power at the focus). Emission was detected by an avalanche photodiode (PDM Series, Micro Photon Devices) with a 550 nm filter (88-nm bandpass).
Prostate cell measurements. LNCaP cells were seeded in each well of a 96-well plate at a density of 25,000 cells per well in triplicate for each condition. Fluorescence was quantified by the IncuCyte ZOOM live-cell imaging microscope system (Sartorius) and analyzed using IncuCyte ZOOM 2016B edition software. Four fields of view, predetermined by the software, were imaged for each well of the 96-well plate, every 4 h. The total object integrated intensity values were compiled for each well at each time point. No ROIs were selected; instead, collected fields were quantified in their entirety. To determine total object integrated intensity values, cells were analyzed by the 'top hat' background subtraction algorithm to subtract non-uniform background (Essen BioScience, IncuCyte Background Fluorescence Technical Note). Radius values for fluorescence masking were calibrated to 1.3× the radius of the largest cell-associated fluorescent object in the representative image set. Fluorescence (arbitrary units) values of images from control wells (that is, untreated iGABASnFR transfected for GABA/vigabatrin experiments; iGABASnFR + empty vector transfected for GAD1 experiments) were thresholded to display a fluorescent object count of zero at the time of the first scan. The above analysis parameters were applied across all images within an experiment. Fluorescence values for transfection controls (empty vector, that is, no mito-iGABASnFR) were less than 0.1% but were nevertheless subtracted at each time point for the corresponding treatment conditions. Primary rat hippocampal neuron cultures. All animal procedures were approved by the Institutional Animal Care and Use and Institutional Biosafety Committees at the HHMI Janelia Research Campus. A mixed cell culture (neurons and glia) was prepared from Sprague Dawley rat pups (Charles River Laboratories). Briefly, P0 pups (either sex) were decapitated and the brains were dissected into ice-cold neural dissection solution (10 mM HEPES, Sigma, in HBSS, Invitrogen, pH 7.4). Cortical tissue was dissected and cut into small pieces to facilitate enzyme digestion. Cortex pieces were transferred using a large bore pipette into a 15 ml conical tube and incubated with enzyme digest solution (Papain, Worthington Biologicals) at 37 °C for 30 min. After 30 min, the enzyme solution was removed and plating media (MEM media containing 10% fetal bovine serum) was added and tissue pieces were triturated resulting in mostly single cells. The cell suspension was filtered using a 45 μm filter. The filtered cell suspension was centrifuged, and the resulting cell pellet was resuspended with plating media and counted. Cells were plated onto coverslips coated with poly-d-lysine (Sigma) and kept at 37 °C, 5% CO 2 in Plating Media. For viral infection, 1 µl of 10 13 genomic copies per milliliter (GC ml −1 ) was diluted into NbActiv4 and added on DIV3, with 50% of the media exchanged for fresh media every 4 d.
Imaging was performed on DIV14. Growth media was replaced with an imaging buffer containing 10 mM HEPES, 145 mM NaCl, 2.5 mM KCl, 10 mM d-glucose, 2 mM CaCl 2 , 1 mM MgCl 2 , pH 7.4. Images were collected on a Nikon Eclipse Ti2 wide-field fluorescence microscope with a Plan Apo ×20 0.75 numerical aperture objective. Fluorescence was excited with a 470 nm LED and emission collected through a 525 nm (36 nm bandpass) filter. Images were collected at 50 Hz. Field stimulation was achieved with a WPI stimulus isolator, 1 ms, 90 mA, 50 Hz, platinum bar electrodes held in place with a bespoke holder.
Hippocampal slices. All animal procedures were conducted in accordance with the European Commission Directive (86/609/EEC) and the United Kingdom Home Office (Scientific Procedures) Act (1986). Young C57BL/6J mice (Envigo, 3-4 weeks of age) male and female, were anaesthetized using isoflurane (5% induction, 1.5-2.5% v/v). Upon loss of pedal withdrawal reflexes, the animal was secured in a stereotaxic frame (David Kopf Instruments). Perioperative analgesics were administered (subcutaneous buprenorphine, 60 µg kg −1 ) and the scalp was shaved and disinfected using three washes of topical chlorhexidine. A small midline incision was made and the skull was exposed. A craniotomy was performed over the right hemisphere using a high-speed hand drill (Proxxon) equipped with a 0.4 mm circular drill burr. The location overlaid the medial hippocampus (Stereotactic coordinates were 60% of the anterio-posterior distance from Bregma to lambda and 2.5 mm lateral to midline). Once exposed, a warmed artificial cerebrospinal fluid (aCSF) variant (cortex buffer; 125 mM NaCl, 5 mM KCl, 10 mM HEPES, 10 mM glucose, 2 mM CaCl 2 , 2 mM MgSO 4 ) was applied to the skull and cortical surface throughout the procedure.
Pressure injections of AAV2/1.hSynapsin.iGABASnFR (totaling 0.1-1 × 10 10 genomic copies in a volume not exceeding 200 nl) were carried out using a pulled glass micropipette stereotactically guided to a depth of 1.3 mm beneath the cortical surface, at a rate of approximately 1 nl s −1
. The total injection volume was delivered in three steps, reducing depth by 100 μm at each step. Once delivery was completed, pipettes were left in place for 5 min before being retracted. The surgical wound was closed with absorbable 7-0 sutures (Ethicon Endo-Surgery GmbH) and the animal was left to recover in a heated chamber. Meloxicam (subcutaneous, 1 mg kg
) was subsequently administered once daily for up to 2 d following surgery. Mice were killed by transcardial perfusion with ice-cold sucrose-enriched slicing medium (105 mM sucrose, 60 mM NaCl, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 15 mM glucose, 1.3 mM ascorbic acid, 3 mM Na pyruvate, 0.5 mM CaCl 2 and 7 mM MgCl 2 , saturated with 95% O 2 and 5% CO 2 ). After a 2-4 week incubation period, acute hippocampal slices were prepared for imaging and electrophysiological recordings as below.
Acute 350 μm thick hippocampal slices were obtained from 5-7-week-old C57BL/6 J mice (Envigo), as specified, in full compliance with national guidelines on animal experimentation. Slices were prepared in an ice-cold slicing solution described below, stored in the slicing solution at 34 °C for 15 min before being transferred to a submersion chamber for storage in an extracellular solution containing 119 mM NaCl, 2.5 mM KCl, 1.3 mM MgSO 4 , 1 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 2 mM CaCl 2 , 10 mM glucose (osmolarity adjusted to 295-305 mOsM with glucose). All solutions were continuously bubbled with 95% O 2 and 5% CO 2 . Slices were allowed to rest for at least 60 min before recordings started.
For imaging of evoked GABA transients, we used a Femtonics Femto3D-RC imaging system, integrated with patch-clamp electrophysiology (Femtonics) and linked on the same light path to two femtosecond pulse lasers MaiTai (SpectraPhysics-Newport) with independent shutter and intensity control as previously described 12, 13 . Cells were first identified as iGABASnFR-expressing using two-photon imaging at 910 nm and dendrites were followed from the CA1 pyramidal cell soma into stratum radiatum. Once a suitable dendritic segment was found a concentric bipolar stimulating electrode was lowered into position 100 microns distant on the axis of the Schaffer collaterals in stratum radiatum. Dendritic iGABASnFR responses were recorded with a frame scanning ROI placed over a dendritic segment. Scans of 3.5 s duration were made at a sampling frequency of ~200 Hz with 2P excitation at 910 nm. During recording iGABASnFR responses were evoked by paired 100 μs constant-current electrical stimulation of an amplitude that evoked a ~50% maximal field EPSP; recorded through a locally placed 1.5-2 MΩ resistance glass electrode filled with aCSF. Recorded scan data were analyzed using Femtonics MES and traces expressed as ΔF/F. Brain slice electrophysiology. All animal procedures were approved by the Institutional Animal Care and Use and Institutional Biosafety Committees at the HHMI Janelia Research Campus. Mice of either sex (n = 4, C57BL/6J, Charles River, 4 weeks old) were bilaterally injected in the primary somatosensory cortex (1.2 mm posterior, 2.25 mm lateral, relative to Bregma) with 40 nl of AAV2/1.hSynapsin1.iGABASnFR (10 13 GC ml
) at two depths (300 and 600 µm). After 2-4 weeks, mice were deeply anesthetized with isoflurane, and the brain was quickly removed and transferred to an ice-cold sucrose solution containing 150 mM Sucrose, 40 mM NaCl, 4 mM KCl, 1.25 mM NaH 2 PO 4 ⋅H 2 O, 7 mM MgCl 2 , 25 mM NaHCO 3 , 10 mM d-Glucose, 0.5 mM CaCl 2 ⋅2H 2 O (pH 7.3-7.4, 300-310 mOsm). Coronal brain slices were cut (300 µm thick) with a vibrating tissue slicer (VT 1200 S, Leica Microsystems) and subsequently incubated at 37 °C for 1 h in recording solution consisting of 124 mM NaCl, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 1.3 mM MgCl 2 , 26 mM NaHCO 3 , 10 mM d-Glucose, 2 mM CaCl 2 ⋅2H 2 O, 1 mM Na-Ascorbate (pH 7.3-7.4, 290-300 mOsm). The sucrose and recording solutions were constantly bubbled with 95% O 2 and 5% CO 2 . Slices were then transferred to a custom-machined recording chamber, perfused with room-temperature recording solution and held down with a slice anchor (SHD-41/10, Warner Instruments).
Cells expressing iGABASnFR were identified on an upright epifluorescent microscope (Olympus BX-51 WI) equipped with an LED illumination system (470 nm, pE-2, CoolLED). Whole-cell voltage clamp recordings were performed with a Multiclamp 700b (Molecular Devices) amplifier. Patch-clamp pipettes were pulled on a horizontal puller (P-97, Sutter Instruments) to a tip resistance of 4 to 8 MΩ and filled with internal solution containing: 115 mM Cs-methanesulfonate, 15 mM CsCl, 3.5 mM Mg-ATP, 5 mM NaF, 10 mM EGTA, 10 mM HEPES, 3 mM QX-315 (pH: 7.3-7.4, 280-290 mOsm). For membrane voltage measurements in current clamp, we used 130 mM K-methanesulfonate, 1 mM MgCl 2 , 1 mM Mg-ATP, 5 mM NaCl, 1 mM Na-ATP, 10 mM HEPES, 14 mM Phosphocreatine (pH: 7.3-7.4, 280-290 mOsm). Synaptic responses were evoked with short square pulses (0.1 ms duration, 10 s interstimulation interval) delivered to a bipolar stimulating electrode (TM33CCNON, World Precision Instruments) through a stimulus isolator (A365, World Precision Instruments). Pulse amplitude was set such that single evoked PSCs were reliably excited with minimum current (range 0.3-0.6 mA). Series resistance was compensated at least 60%. Evoked EPSCs were recorded while holding the cell at −70 mV and IPSCs at 0 mV. Ten stimulus responses were recorded and averaged for each cell.
Spontaneously occurring excitatory and inhibitory PSCs were analyzed in recording segments between stimulation pulses. The PSC peak times were manually identified, and amplitude was determined by subtracting the recording baseline averaged over the 10-50 ms time period before the PSC. Only PSCs with amplitudes >20 pA were considered sufficiently distinct from recording noise (~10 pA, peak). PSC frequency was determined by counting the number of spontaneously occurring PSCs per 100 s observation window.
Statistical significance was computed using unpaired Mann-Whitney U-test. Statistics were computed using Prism (GraphPad). ). Each mouse's head was gently restrained by a toothbar (David Kopf 923-B). A flap of skin and underlying tissue covering the parietal bones and the intraparietal bone was removed. The sutures of the frontal and parietal bones were covered with a thin layer of cyanoacrylate glue. A ring-shaped titanium headbar was glued over the left parietal cortex. We carefully drilled a ~4.5 mm craniotomy (centered in the middle of the left parietal bone) using a high-speed microdrill (Osada, EXL-M40). The dura mater was left intact. Glass capillaries (Drummond Scientific, 3-000-203-G/X) were pulled and beveled (30° angle, 20 µm outer diameter). Using a precision injector (Drummond Scientific, Nanoject III) we injected AAV2/1.hSynapsin1.iGABASnFR virus (30 nl, 5E11 GC ml , 300 µm deep) into 6-8 positions within the left visual cortex. The craniotomy was closed with a 4 mm round no. 1 cover glass and sealed with cyanoacrylate glue. Animals were imaged 5-15 weeks after surgery.
Volumetric raster two-photon imaging was performed, using a piezo objective mount to perform a 400 µm axial scan in 10 µm increments (volume period 12.05 s). Anesthesia (1.5% isoflurane v/v) was initiated at the onset of frame 40 (8 min) and stopped at the onset of frame 120 (24 min). Basal fluorescence F 0 was calculated by averaging the image intensity over the period prior to anesthesia onset, for each depth.
Seizure model. All animal procedures were conducted in accordance with the European Commission Directive (86/609/ EEC) and the United Kingdom Home Office (Scientific Procedures) Act (1986). Male C57BL/6J mice (from Harlan, 7-8-week-old) were anesthetized with isoflurane (5% induction, 1.5-2.5% v/v) and mounted in a stereotaxic frame (Kopf Instruments). Injection of 200 nl (100 nl min −1 ) of AAV2/1.hSynapsin1.iGABASnFR variants (titer > 10 13 GC ml −1 , except for F102G variant 6 × 10 12 GC ml −1 ) into layer 2/3 of primary visual cortex (Antero-posterior: −2.8 mm from Bregma and Lateral: 2.4 mm, depth: 0.3 mm below the pia) was performed using a microinjection pump (WPI Ltd.), a 5 µl Hamilton syringe and a 33-gauge needle (Esslab Ltd.). Two to three weeks later, a craniotomy was performed over the visual cortex and electrocorticogram (ECoG) electrodes and a head-plate (Neurotar) were implanted under isoflurane anesthesia. After recovery, the mice were trained to tolerate brief sessions of immobilization via the head-plate. On the day of the experiment, pilocarpine (3.5 M, 0.2-0.3 μl) was injected into layer 5 (approximately 1-2 mm from the imaging area, depth 0.5 mm) close to the region of interest. Imaging was performed with a FV1200MPE multi-photon laser scanning microscope (Olympus), coupled to a Chameleon Ultra pulsed laser (Coherent, wavelength 908 nm). The ECoG was acquired via a MultiClamp 700B amplifier (Molecular Devices), time-stamped with the imaging data. ECoG data were bandpass-filtered from 0.1 to 300 Hz and digitized at 1 kHz. The imaging frame rate was typically 10 Hz, and the region of interest was up to 0.25 × 0.25 mm 2 . For the data shown here the fluorescence was averaged across the entire region of interest, or where iGABASnFR was expressed. To average the time-course of the GABA fluorescence transient occurring during interictal spiking, a shift and mean algorithm 52 was applied to blocks of frames straddling each spike. Imaging experiments were performed using 5-d old embryos. The zebrafish were immobilized and mounted to an imaging chamber as described previously 53 . Briefly, the muscles of the zebrafish were paralyzed by a short (up to 30 seconds) bath incubation with alpha-bungarotoxin (1 mg ml −1 , Thermo Fischer Scientific, B1601) dissolved in external solution. After the fish became immobile, the zebrafish were further mounted to a custom-made chamber using 2% agarose (Sigma-Aldrich, A9414) and placed under a light-sheet microscope with a ×16 objective lens (Nikon, CFI75 LWD ×16 W). Imaging was performed using a 488 nm laser (180 μW) and a 525/50 emission filter (Semrock, FF03-525/50) with a frame rate of 30 frames s -1 .
To record swim signals from the axonal bundles of spinal motoneurons in the tail, we attached a pair of large barrel electrodes to the dorsal left and right sides of the tail. Signals were amplified by an amplifier (Molecular Devices, AxoClamp 700B) and recorded at 6 kHz using custom software written in C# (Microsoft). For synchronization between the swim signals and neural activity images, camera trigger signals that initiate the acquisition of individual frames in the light-sheet microscope were simultaneously recorded with the swim signals. During the experiments, we projected red visual stimuli (red or black gratings with bars 2 mm thick) onto the bottom of the fish chamber. The speed of the moving visual stimulus alternated between 0 mm s −1 (stopped) and 2 mm s −1 (moving forward) every 10 s. This forward movement of visual stimulus reliably triggered swimming (Fig. 5c) .
Statistical tests. Data are presented as the mean with s.e.m. or s.d., as noted in each case. All values of n are provided; no data were excluded. For comparisons between two datasets, a two-sided Student's t-test was used, unless specified otherwise.
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Sample size
No statistical methods were used to determine sample size. Experiments were performed enough times to achieve consistent results and permit statistical analysis when appropriate.
Data exclusions No data points were excluded.
Replication
No attempts at replication failed. All experiments are shown. All experiments were repeated at least twice.
Randomization Randomization is not relevant to this study because no comparisons between experimental groups or treatments were made.
Blinding
No blinding was performed because these experiments were performed to optimize and characterize a molecular toolset, not test a hypothesis.
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Mycoplasma contamination
Cell lines were routinely checked to ensure authenticity and absence of mycoplasma infection. All tested negative.
Commonly misidentified lines (See ICLAC register)
No commonly misidentified cell lines were used.
Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research
Laboratory animals
Neuronal cultures were prepared from Sprague-Dawley rat pups (Charles River Laboratories; P0 pups, either sex). Brain slices were prepared from C57BL/6J mice (2 -4 weeks of age, either sex). Anaesthesia experiments were performed on Parvalbumin-T2A-Cre mice (females, 6-8 weeks at the time of the surgery, Jax #012358) and VGAT-IRES-Cre mice (males, 8-12 weeks at the time of the surgery, Jax #028862). Seizure models was performed on male C57BL/6J mice (from Harlan, UK, 7-8-week-old). Transgenic zebrafish (5 dpf, sex not yet genetically determined) were generated and maintained in-house.
Wild animals
The study did not use wild animals.
